Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Research Progress of Hydromorphone in Clinical Application

L. Liu, M. Xu, J. Wang, Y. Hu, Z. Huang

. 2025 ; 74 (1) : 41-48. [pub] 20250321

Language English Country Czech Republic

Document type Journal Article, Review

Persistent link   https://www.medvik.cz/link/bmc25008998

A common opioid analgesic for cancer pain and, to a lesser extent, non-cancer pain, is hydromorphone (HM). Oral formulations as well as subcutaneous, intravenous, and other routes are frequently used for its administration. Its pharmacokinetics and pharmacodynamics have also been extensively researched. This article examines the pharmacological properties of hydromorphone and the development of its use both domestically and internationally with the goal of serving as a reference for the sensible clinical use of this medication. Key words Hydromorphone, Pharmacological action, Route of administration, Cancer pain, Adverse effects.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25008998
003      
CZ-PrNML
005      
20250502104614.0
007      
ta
008      
250411s2025 xr f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.935354 $2 doi
035    __
$a (PubMed)40116549
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Liu, L. $u Department of Respiratory Medicine, Affiliated Renhe Hospital/Second Clinical Medical College of China Three Gorges University, Yichang, Hubei, China. 64769680@qq.com
245    10
$a Research Progress of Hydromorphone in Clinical Application / $c L. Liu, M. Xu, J. Wang, Y. Hu, Z. Huang
520    9_
$a A common opioid analgesic for cancer pain and, to a lesser extent, non-cancer pain, is hydromorphone (HM). Oral formulations as well as subcutaneous, intravenous, and other routes are frequently used for its administration. Its pharmacokinetics and pharmacodynamics have also been extensively researched. This article examines the pharmacological properties of hydromorphone and the development of its use both domestically and internationally with the goal of serving as a reference for the sensible clinical use of this medication. Key words Hydromorphone, Pharmacological action, Route of administration, Cancer pain, Adverse effects.
650    12
$a hydromorfon $x terapeutické užití $x farmakologie $x aplikace a dávkování $7 D004091
650    _2
$a lidé $7 D006801
650    12
$a opioidní analgetika $x terapeutické užití $x farmakologie $x škodlivé účinky $7 D000701
650    _2
$a zvířata $7 D000818
650    _2
$a nádorová bolest $x farmakoterapie $7 D000072716
650    _2
$a bolest $x farmakoterapie $7 D010146
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Xu, M. $u Department of Respiratory Medicine, Affiliated Renhe Hospital/Second Clinical Medical College of China Three Gorges University, Yichang, Hubei, China
700    1_
$a Wang, J. $u Department of Respiratory Medicine, Affiliated Renhe Hospital/Second Clinical Medical College of China Three Gorges University, Yichang, Hubei, China
700    1_
$a Hu, Y. $u Department of Respiratory Medicine, Affiliated Renhe Hospital/Second Clinical Medical College of China Three Gorges University, Yichang, Hubei, China
700    1_
$a Huang, Z. $u Department of Respiratory Medicine, Affiliated Renhe Hospital/Second Clinical Medical College of China Three Gorges University, Yichang, Hubei, China
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 74, č. 1 (2025), s. 41-48
856    41
$u https://pubmed.ncbi.nlm.nih.gov/40116549 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y p $z 0
990    __
$a 20250411 $b ABA008
991    __
$a 20250502104606 $b ABA008
999    __
$a ok $b bmc $g 2307249 $s 1246076
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 74 $c 1 $d 41-48 $e 20250321 $i 1802-9973 $m Physiological research $n Physiol Res $x MED00003824
LZP    __
$b NLK116 $a Pubmed-20250411

Find record

Citation metrics

Archiving options